Nanopore is a biotech company developing and selling nanopore sequencing products (including the portable DNA sequencer, MinION) for the direct, electronic analysis of single molecules.
Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use.
Nanopore Technologies was founded in 2005 as a spin-out from the University of Oxford by Hagan Bayley, Gordon Sanghera, and Spike Willcocks. The company is headquartered in Oxford, Oxfordshire, , with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India.
Nanopore Technologies offer real-time nanopore-based DNA/RNA sequencing technology: accessible, easy to use and fully scalable for any requirement.
Nanopore Technologies' novel, electronics-based DNA/RNA sequencing technology is being used in nearly 100 countries, for a range of biological research applications. These include large scale human genomics, cancer research, microbiology, plant science and environmental research.
Nanopore Technologies is backed by GIC, GT Healthcare Capital Partners, IP Group Plc, Amgen, Baillie Gifford, Railpen Investments, International Holdings Company (IHC) and others. The company raised £84.4M in new round on Oct 13, 2020. This brings Nanopore's total funding to £799.6M to date.